Re: Debt

...We Welcome You to the Zenith Epigenetics Hub withIn The AGORACOM COMMUNITY!

Zenith's BET Inhibitor ZEN-3694 is Currently Being Evaluated in Multiple Oncology Clinical Trials

Reply New Message

Prev Message Back To Forum Threaded View Next Message

KayakerBC

Rank: Treasurer [?]

Points: 1691 [?]

Votes: 23 Score: 2.6 [?]

Your Vote:

Please Log In to Vote

Did you know? You can earn activity points by filling your profile with information about yourself (what city you live in, your favorite team, blogs etc.)

Re: Debt

in response to

Re: Debt

KOO-KOO2

posted on Apr 06, 2022 10:35AM

Phase I/Ib Trial Evaluating the Safety and Efficacy of BET Inhibitor, ZEN003694:

I'm not betting on that one. I think a buyout will require a Phase II study.

2 Recommendations

Reply New Message

Prev Message Back To Forum Threaded View Next Message

Please to post a reply